ABL1 and myeloid sarcoma: The most common genetic abnormalities involved in the pathogenesis of de novo MS are t(8;21), inv(16), KMT2Ar, JAK2 V617F, and in secondary cases, KMT2Ar and BCR::ABL1 [20].